BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
Keyword: Incretin
1
Glucagon-like peptide 1 receptor agonist: A potential game changer for cholangiocarcinoma
9/10/2024 9:27:23 AM | Browse: 189 | Download: 519
2
Role of incretins and glucagon receptor agonists in metabolic dysfunction-associated steatotic liver disease: Opportunities and challenges
5/22/2024 11:33:24 AM | Browse: 98 | Download: 496
3
Rikkunshito increases appetite by enhancing gastrointestinal and incretin hormone levels in patients who underwent pylorus-preserving pancreaticoduodenectomy: A retrospective study
5/26/2023 9:50:16 AM | Browse: 240 | Download: 1003
4
Diabetes and fatty liver: Involvement of incretin and its benefit for fatty liver management
5/15/2023 3:23:22 PM | Browse: 322 | Download: 1040
5
Incretin based therapy and pancreatic cancer: Realising the reality
7/4/2022 12:30:52 PM | Browse: 602 | Download: 1575
6
Pharmacological inhibition of diacylglycerol acyltransferase-1 and insights into postprandial gut peptide secretion
11/13/2017 1:14:28 AM | Browse: 1270 | Download: 2504
7
Role of bile acids in the regulation of the metabolic pathways
7/6/2016 1:52:00 PM | Browse: 1402 | Download: 2665
8
New perspectives on exploitation of incretin peptides for the treatment of diabetes and related disorders
11/11/2015 10:00:00 AM | Browse: 1302 | Download: 2162
9
Asymmetric dimethylarginine, a biomarker of cardiovascular complications in diabetes mellitus
5/21/2015 2:15:00 PM | Browse: 1393 | Download: 1700
10
Dipeptidyl peptidase-4: A key player in chronic liver disease
9/16/2014 1:19:00 PM | Browse: 1523 | Download: 1609
Write to the Help Desk
© 2004-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345